Seminars in Pediatric Surgery
Volume 14, Issue 3 , Pages 167-174 , August 2005

Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis

  • Jiexiong Feng, MD, PhD
    • ,
  • Osama N. El-Assal, MD, PhD
    • ,
  • Gail E. Besner, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Gail E. Besner, MD, Professor of Surgery and Pediatrics, Department of Surgery, Children's Hospital, ED321, 700 Children's Drive, Columbus, OH 43205

References 

  1. Lee JS , Polin RA . Treatment and prevention of necrotizing enterocolitis . Semin Neonatol . 2003;8:449–459
  2. Kosloske AM . Epidemiology of necrotizing enterocolitis . Acta Pediatr Suppl . 1994;396:2–7
  3. Hsueh W , Caplan MS , Qu XW , et al.  Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts . Pediatr Dev Pathol . 2002;6:6–23
  4. Caplan MS , Jilling T . New concepts in necrotizing enterocolitis . Curr Opin Pediatr . 1998;13:111–115
  5. Nadler EP , Standford A , Zhang XR , et al.  Intestinal cytokine gene expression in infants with acute necrotizing enterocolitis: interleukin-11 mRNA expression inversely correlates with extent of disease . J Pediatr Surg . 2001;36:1122–1129
  6. Ford H , Watkins S , Reblock K , et al.  The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis . J Pediatr Surg . 1997;32:275–282
  7. Morecroft JA , Spitz L , Hamilton PA , et al.  Plasma interleukin-6 and tumour necrosis factor levels as predictors of disease severity and outcome in necrotizing enterocolitis . J Pediatr Surg . 1994;29:798–800
  8. Edelson MB , Bagwell CE , Rozycki HJ . Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis . Pediatrics . 1999;103:766–771
  9. Caplan MS , Sun XM , Hseuh W , et al.  Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis . J Pediatr . 1990;116:960–964
  10. Besner GE , Higashiyama S , Klagsbrun M . Isolation and characterization of a macrophage-derived heparin-binding growth factor . Cell Reg . 1990;1:811–819
  11. Higashiyama S , Abraham JA , Miller JC , et al.  A heparin-binding EGF-like growth factor secreted by macrophage-like cells that is related to epidermal growth factor . Science . 1991;251:936–939
  12. Davis-Fleischer KM , Besner GE . Structure and function of heparin-binding EGF-like growth factor (HB-EGF) . Front Biosci . 1998;3:d288–d299
  13. El-Assal ON , Besner GE . Heparin-binding epidermal growth factor-like growth factor and intestinal ischemia-reperfusion injury . Semin Pediatr Surg . 2004;13:2–10
  14. Chobotova K , Muchmore ME , Carver J , et al.  The mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha . J Clin Endocrinol Metab . 2002;87:5769–5777
  15. Elenius K , Paul S , Allison G , et al.  Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation . EMBO J . 1997;16:1268–1278
  16. Nishi E , Prat A , Hospital V , et al.  N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration . EMBO J . 2001;20:3342–3350
  17. Ellis PD , Hadfield KM , Pascall JC , et al.  Heparin-binding epidermal-growth-factor-like growth factor gene expression is induced by scrape-wounding epithelial cell monolayers: involvement of mitogen activated protein kinase cascades . Biochem J . 2001;354:99–106
  18. Jin K , Mao XO , Sun Y , et al.  Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo . J Neurosci . 2002;22:5365–5373
  19. Frank GD , Mifune M , Inagami T , et al.  Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta . Mol Cell Biol . 2003;23:1581–1589
  20. Kayanoki Y , Higashiyama S , Suzuki K , et al.  The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells . Biochem Biophys Res Commun . 1999;259:50–55
  21. Cribbs RK , Harding PA , Luquette MH , et al.  Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing . J Burn Care Rehabil . 2002;23:116–125
  22. Marikovsky M , Breuing K , Liu PY , et al.  Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury . Proc Natl Acad Sci U S A . 1993;90:3889–3893
  23. McCarthy DW , Downing MT , Brigstock DR , et al.  Production of heparin-binding epidermal growth factor-like growth factor (HBEGF) at sites of thermal injury in pediatric patients . J Invest Dermatol . 1996;106:49–56
  24. Xia G , Rachfal AW , Martin AE , et al.  Upregulation of endogenous heparin-binding EGF-like growth factor(HB-EGF) expression after intestinal ischemia reperfusion injury . J Invest Surg . 2003;16:57–63
  25. Kawahara N , Mishima K , Higashiyama S , et al.  The gene for heparin-binding epidermal growth factor-like growth factor is stress-inducible: its role in cerebral ischemia . J Cereb Blood Flow Metab . 1999;19:307–320
  26. Nishi H , Nishi KH , Johnson AC . Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia . Cancer Res . 2002;62:827–834
  27. Yano T , Yazima S , Hagiwara K , et al.  Activation of epidermal growth factor receptor in the early phase after renal ischemia-reperfusion in rat . Nephron . 1999;81:230–233
  28. Sondeen JL , Dubick MA , Yu Y , et al.  Hemorrhage and renal ischemia-reperfusion upregulates the epidermal growth factor receptor in rabbit duodenum . J Lab Clin Med . 1999;134:641–648
  29. El-Assal O, Besner G. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3-K/Akt and MEK/ERK1/2 activation. Gastroenterology (in press).
  30. Sakai M , Zhang M , Homaa T , et al.  Production of heparin binding epidermal growth factor-like growth factor transcription in renal epithelial cells . Exp Nephrol . 2001;9:28–39
  31. Miyazaki Y , Hiraoka S , Tsutsui S , et al.  Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells . Gastroenterology . 2001;120:108–116
  32. Tamaoki J , Isono K , Takeyama K , et al.  Ultrafine carbon black particles stimulate proliferation of human airway epithelium via EGF receptor-mediated signaling pathway . Am J Physiol Lung Cell Mol Physiol . 2004;287:L1127–L1133
  33. Koh YH , Suzuki K , Che W , et al.  Inactivation of glutathione peroxidase by NO leads to the accumulation of H2O2 and the induction of HB-EGF via c-Jun NH2-terminal kinase in rat aortic smooth muscle cells . FASEB J . 2001;15:1472–1474
  34. Yoshizumi M , Kourembanas S , Temizer DH , et al.  Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells . J Biol Chem . 1992;267:9467–9469
  35. Jayne DG , Perry SL , Morrison E , et al.  Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases . Br J Cancer . 2000;82:1233–1238
  36. Sakuda S , Tamura S , Yamada A , et al.  NF-kappa B activation in non-parenchymal liver cells after partial hepatectomy in rats: possible involvement in expression of heparin-binding epidermal growth factor-like growth factor . J Hepatol . 2002;36:527–533
  37. Pan Z , Kravchenko VV , Ye RD . Platelet-activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocytes . Correlation with an increased kappa B binding activity. J Biol Chem . 1995;270:7787–7790
  38. Asano K , Nakamura H , Lilly CM , et al.  Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells . J Clin Invest . 1997;99:1057–1063
  39. Tanida S , Joh T , Itoh K , et al.  The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells . Gastroenterology . 2004;127:559–569
  40. Takenobu H , Yamazaki A , Hirata M , et al.  The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades . J Biol Chem . 2003;278:17255–17262
  41. Michalsky MP , Kuhn A , Mehta V , et al.  Heparin-binding EGF-like growth factor decreases apoptosis in intestinal epithelial cells in vitro . J Pediatr Surg . 2001;36:1130–1135
  42. Chobotova K , Karpovich N , Carver J , et al.  Heparin-binding epidermal growth factor and its receptors mediate decidualization and potentiate survival of human endometrial stromal cells . J Clin Endocrinol Metab . 2005;90:913–919
  43. Nguyen HT , Bride SH , Badawy AB , et al.  Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell- and region-specific manner and acts to inhibit apoptosis . Am J Pathol . 2000;156:889–898
  44. Bryson JM , Coy PE , Gottlob K , et al.  Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death . J Biol Chem . 2002;277:11392–11400
  45. Horikawa M , Higashiyama S , Nomura S , et al.  Upregulation of endogenous heparin-binding EGF-like growth factor and its role as a survival factor in skeletal myotubes . FEBS Lett . 1999;459:100–104
  46. Kuhn MA , Xia G , Mehta VB , et al.  Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo . Antioxid Redox Signal . 2002;4:639–646
  47. Pillai SB , Turman MA , Besner GE . Heparin-binding EGF-like growth factor is cytoprotective for intestinal epithelial cells exposed to hypoxia . J Pediatr Surg . 1998;33:973–978
  48. Xia G , Martin AE , Mchalsky MP , et al.  Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury . J Pediatr Surg . 2002;37:1081–1087
  49. Lara-Marquez ML , Mehta V , Michalsky MP , et al.  Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells . Nitric Oxide . 2002;6:142–152
  50. Mehta VB , Besner GE . Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor . J Immunol . 2003;171:6014–6022
  51. Wang YD , De Vos J , Jourdan M , et al.  Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells . Oncogene . 2002;21:2584–2592
  52. Pillai SB , Hinman CE , Luquette MH , et al.  Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury . J Surg Res . 1999;87:225–231
  53. Xia G , Martin AE , Besner GE . Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury . J Pediatr Surg . 2003;38:434–439
  54. Xia G , Lara-Marquez M , Luquette MH , et al.  Heparin-binding EGF-like growth factor decreases inducible nitric oxide synthase and nitric oxide production after intestinal ischemia/reperfusion injury . Antioxid Redox Signal . 2001;3:919–930
  55. Martin A, Besner G. Timing, route and dose of administration of heparin-binding EGF-like growth factor (HB-EGF) in protection against intestinal ischemia-reperfusion injury. J Pediatr Surg (in press).
  56. Barlow B , Santulli TV , Heird WC , et al.  An experimental study of acute neonatal enterocolitis: the importance of breast milk . J Pediatr Surg . 1974;9:587–595
  57. Caplan MS , Hedlund E , Adler L , et al.  Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis . Pediatr Pathol . 1994;14:1017–1028
  58. Halpern MD , Dominguez JA , Dvorakova K , et al.  Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor . J Pediatr Gastroenterol Nutr . 2003;36:126–133
  59. Michalsky MP , Lara-Marquez M , Chun L , et al.  Heparin-binding EGF-like growth factor is present in human amniotic fluid and breast milk . J Pediatr Surg . 2002;37:1–6
  60. Sanderson IR , Walker WA . Establishment of a human fetal small intestinal epithelial cell line . Int Arch Allergy Immunol . 1995;107:396–397
  61. Halac E , Halac J , Begue EF , et al.  Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial . J Pediatr . 1990;117:132–138
  62. McGuire W , Anthony MY . Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review . Arch Dis Child Fetal Neonatal Ed . 2003;88:F11–F14
  63. Foster J, Cole M. Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth-weight neonates. Cochrane Database Syst Rev CD001816, 2004
  64. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev CD000361, 2004
  65. Shah P, Shah V. Arginine supplementation for prevention of necrotising enterocolitis in preterm infants. Cochrane Database Syst Rev CD004339, 2004
  66. Bury RG, Tudehope D. Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev CD000405, 2001
  67. Dani C , Biadaioli R , Bertini G , et al.  Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants . A prospective double-blind study. Biol Neonate . 2002;82:103–108
  68. Lin HC , Su BH , Chen AC , et al.  Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants . Pediatrics . 2005;115:1–4
  69. Kennedy KA, Tyson JE, Chamnanvanikij S. Early versus delayed initiation of progressive enteral feedings for parenterally fed low birth weight or preterm infants. Cochrane Database Syst Rev CD001970, 2000

PII: S1055-8586(05)00033-8

doi: 10.1053/j.sempedsurg.2005.05.005

Seminars in Pediatric Surgery
Volume 14, Issue 3 , Pages 167-174 , August 2005

Article Tools

* Image Usage & Resolution